These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15120256)

  • 1. Generation of DOTA-conjugated antibody fragments for radioimmunoimaging.
    Smith-Jones PM; Solit DB
    Methods Enzymol; 2004; 386():262-75. PubMed ID: 15120256
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood pharmacokinetics of various monoclonal antibodies labeled with a new trifunctional chelating reagent for simultaneous conjugation with 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and biotin before radiolabeling.
    Wang Z; Mårtensson L; Nilsson R; Bendahl PO; Lindgren L; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7171s-7177s. PubMed ID: 16203818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal-Chelating Polymers (MCPs) with Zwitterionic Pendant Groups Complexed to Trastuzumab Exhibit Decreased Liver Accumulation Compared to Polyanionic MCP Immunoconjugates.
    Liu P; Boyle AJ; Lu Y; Adams J; Chi Y; Reilly RM; Winnik MA
    Biomacromolecules; 2015 Nov; 16(11):3613-23. PubMed ID: 26469142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and renal clearance of 111In-labeled DOTA-conjugated antibody fragments.
    Tsai SW; Li L; Williams LE; Anderson AL; Raubitschek AA; Shively JE
    Bioconjug Chem; 2001; 12(2):264-70. PubMed ID: 11312688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent.
    Dennis MS; Jin H; Dugger D; Yang R; McFarland L; Ogasawara A; Williams S; Cole MJ; Ross S; Schwall R
    Cancer Res; 2007 Jan; 67(1):254-61. PubMed ID: 17210705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MANOTA: a promising bifunctional chelating agent for copper-64 immunoPET.
    Moreau M; Poty S; Vrigneaud JM; Walker P; Guillemin M; Raguin O; Oudot A; Bernhard C; Goze C; Boschetti F; Collin B; Brunotte F; Denat F
    Dalton Trans; 2017 Oct; 46(42):14659-14668. PubMed ID: 28861553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and applications of copper-64 radiopharmaceuticals.
    Sun X; Anderson CJ
    Methods Enzymol; 2004; 386():237-61. PubMed ID: 15120255
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.
    Li L; Yazaki PJ; Anderson AL; Crow D; Colcher D; Wu AM; Williams LE; Wong JY; Raubitschek A; Shively JE
    Bioconjug Chem; 2006; 17(1):68-76. PubMed ID: 16417253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
    Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
    Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOTAGA-trastuzumab. A new antibody conjugate targeting HER2/Neu antigen for diagnostic purposes.
    Moreau M; Raguin O; Vrigneaud JM; Collin B; Bernhard C; Tizon X; Boschetti F; Duchamp O; Brunotte F; Denat F
    Bioconjug Chem; 2012 Jun; 23(6):1181-8. PubMed ID: 22519915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotinylated polyacrylamide-based metal-chelating polymers and their influence on antigen recognition following conjugation to a trastuzumab Fab fragment.
    Liu P; Boyle AJ; Lu Y; Reilly RM; Winnik MA
    Biomacromolecules; 2012 Sep; 13(9):2831-42. PubMed ID: 22871127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOTA-functionalized polylysine: a high number of DOTA chelates positively influences the biodistribution of enzymatic conjugated anti-tumor antibody chCE7agl.
    Grünberg J; Jeger S; Sarko D; Dennler P; Zimmermann K; Mier W; Schibli R
    PLoS One; 2013; 8(4):e60350. PubMed ID: 23565233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution.
    Al-Ejeh F; Darby JM; Thierry B; Brown MP
    Nucl Med Biol; 2009 May; 36(4):395-402. PubMed ID: 19423007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging.
    Xu H; Baidoo K; Gunn AJ; Boswell CA; Milenic DE; Choyke PL; Brechbiel MW
    J Med Chem; 2007 Sep; 50(19):4759-65. PubMed ID: 17725340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA.
    Lewis MR; Kao JY; Anderson AL; Shively JE; Raubitschek A
    Bioconjug Chem; 2001; 12(2):320-4. PubMed ID: 11312695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET.
    Mume E; Orlova A; Malmström PU; Lundqvist H; Sjöberg S; Tolmachev V
    Nucl Med Biol; 2005 Aug; 32(6):613-22. PubMed ID: 16026708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence.
    Miranda ACC; Durante ACR; Fuscaldi LL; Barbezan AB; de Lima CR; Perini E; de Araújo EB
    Bioorg Med Chem; 2021 Mar; 33():115996. PubMed ID: 33494011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of methods for large scale preparation of antibody ligand conjugates.
    Wu C; Gansow OA; Brechbiel MW
    Nucl Med Biol; 1999 Apr; 26(3):339-42. PubMed ID: 10363806
    [No Abstract]   [Full Text] [Related]  

  • 19. Arming antibodies: prospects and challenges for immunoconjugates.
    Wu AM; Senter PD
    Nat Biotechnol; 2005 Sep; 23(9):1137-46. PubMed ID: 16151407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro evaluation of 111In-CHX-A"-DTPA-labeled anti-VEGF monoclonal antibody bevacizumab.
    Hosseinimehr SJ; Orlova A; Tolmachev V
    Hum Antibodies; 2010; 19(4):107-11. PubMed ID: 21178282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.